Florida SB 190: Controlled Substances

Bill Text

190 
Impact of Perimenopause and Menopause on Women’s Health 
2025-10-14T12:28:01Z 
Requiring the Department of Health to establish a perimenopause and menopause policy workgroup; requiring the department, in collaboration with others, to develop and make publicly available on its website information relating to perimenopause and menopause, etc. 
Original Filed Version 
2026 
S 
2026-07-01T00:00:00Z 
GB 
General Bill 
__ 

 Florida Senate - 2026 SB 190 

 By Senator Sharief 

 35-00601-26 2026190__ 
 1 A bill to be entitled 
 2 An act relating to the impact of perimenopause and 
 3 menopause on women’s health; creating s. 381.995, 
 4 F.S.; requiring the Department of Health to establish 
 5 a perimenopause and menopause policy workgroup; 
 6 providing requirements for the workgroup; requiring 
 7 the department, in collaboration with others, to 
 8 develop and make publicly available on its website 
 9 information relating to perimenopause and menopause; 
 10 providing requirements for such information; providing 
 11 an effective date. 
 12 
 13 Be It Enacted by the Legislature of the State of Florida: 
 14 
 15 Section 1. Section 381.995, Florida Statutes, is created to 
 16 read: 
 17 381.995 Perimenopause and menopause workgroup and 
 18 information.— 
 19 (1)(a) The Department of Health shall establish a 
 20 perimenopause and menopause policy workgroup. The workgroup 
 21 shall: 
 22 1. Develop key messages relating to perimenopause and 
 23 menopause. 
 24 2. Set initiative priorities. 
 25 3. Ensure, in conjunction with diversity and health equity 
 26 stakeholders, that initiatives are representative of diverse 
 27 communities of women and that the messaging resonates, is 
 28 culturally appropriate, and is delivered by trusted messengers. 
 29 4. Create a coordinated communications strategy to focus on 
 30 multiple audiences and use a variety of communications tools to 
 31 reach: 
 32 a. Women and men of all ages. 
 33 b. Employers. 
 34 c. Medical providers. 
 35 5. Consider dissemination points for information, 
 36 including, but not limited to, personal trainers, yoga 
 37 instructors, hairdressers, religious meeting places, and 
 38 community centers. 
 39 6. Support efforts to communicate the science on the safety 
 40 of hormone replacement therapy (HRT) and nonhormonal therapies 
 41 in appropriate patients and their use in improving health for 
 42 menopausal women. 
 43 (b) The workgroup shall be composed of health care 
 44 providers, women who have experienced perimenopause or 
 45 menopause, advocates, and other interested parties and 
 46 associations. 
 47 (2) The Department of Health, in collaboration with the 
 48 workgroup, the Office of Women’s Health, and relevant state 
 49 agencies, shall develop and make publicly available, by posting 
 50 on its website, resources and a website link to materials 
 51 relating to perimenopause and menopause. The resources must 
 52 include, but need not be limited to, all of the following: 
 53 (a) Accurate scientific information on perimenopausal and 
 54 menopausal symptoms and treatment options. 
 55 (b) Information on health risks associated with reduced 
 56 estrogen production and what women can do to stay healthy. 
 57 (c) A downloadable checklist that can be printed and taken 
 58 to a clinician visit and that details recommended preventive 
 59 care for women as they reach and move through midlife and 
 60 provides a set of questions women may want to ask their 
 61 clinician. 
 62 (d) Content adapted from existing clinician-directed 
 63 materials relating to perimenopause and menopause, other federal 
 64 Offices of Women’s Health, and tools created by patient 
 65 education and advocacy organizations. 
 66 Section 2. This act shall take effect July 1, 2026.